© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 4, 307-311,
February 17, 1993
© 1993 Oxford University Press
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Division of Cancer Etiology, National Cancer Institute Rockville, Md
Cancer Epidemiology Unit, University Hospital Uppsala, Sweden
Information Management Services Silver Spring, Md
Correspondence to: Gloria Gridley, Division of Cancer Etiology, National Cancer Institute, 6130 Executive Blvd., EPN 443, Rockville, MD 20852.
Background: To evaluate hypotheses about the relationship between immune alterations and cancer, several investigators have determined cancer incidence in groups of patients with rheumatoid arthritis (RA), a chronic autoimmune disease. The primary finding has been an increased risk of hematopoietic cancers. Purpose: In this study, we have attempted to refine estimates of the association between RA and subsequent development of specific cancers. Methods: We investigated site-specific cancer risk associated with RA in a population-based cohort study of 11683 Swedish men and women with a hospital (inpatient) diagnosis of RA. These case patients were identified from 1965 to 1983 and had follow-up through 1984 by computer linkage of the Swedish Hospital Inpatient Register to the National Swedish Cancer Registry (840 case patients with cancer) and the Swedish Registry of Causes of Death. Cancer risk was estimated by standardized incidence ratios (SIRs) for specific cancers. Results: For men and women overall, there were decreased risks for cancers of the colon (SIR = 0.63; 95% confidence interval [CI] = 0.5-0.9), rectum (SIR = 0.72; 95% CI = 0.5-1.1), and stomach (SIR = 0.63; 95% CI = 0.5-0.9) and an increased risk for lymphomas (SIR = 1.98; 95% CI = 1.5-2.6). Conclusions: The reduced risk for colorectal cancer in patients with RA is consistent with previous studies of RA patients and with reports which state that use of nonsteroidal anti-inflammatory drugs may protect against the development of large bowel cancers. The excess of lymphomas also confirms a number of earlier investigations of RA patients. [J Natl Cancer Inst 85: 307–311, 1993]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T A Simon, A L Smitten, J Franklin, J Askling, D Lacaille, F Wolfe, M C Hochberg, K Qi, and S Suissa Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment Ann Rheum Dis, December 1, 2009; 68(12): 1819 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G R Burmester, P Mease, B A C Dijkmans, K Gordon, D Lovell, R Panaccione, J Perez, and A L Pangan Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases Ann Rheum Dis, December 1, 2009; 68(12): 1863 - 1869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Segoli, T. Keasar, A. R. Harari, and A. Bouskila Limited kin discrimination abilities mediate tolerance toward relatives in polyembryonic parasitoid wasps Behav. Ecol., November 1, 2009; 20(6): 1262 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Kristinsson, L. R. Goldin, M. Bjorkholm, J. Koshiol, I. Turesson, and O. Landgren Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies Haematologica, November 1, 2009; 94(11): 1581 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Vajdic, M. T. van Leeuwen, A. C. Webster, M. R.E. McCredie, J. H. Stewart, J. R. Chapman, J. Amin, S. P. McDonald, and A. E. Grulich Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2297 - 2303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. KHRAISHI Comparative Overview of Safety of the Biologics in Rheumatoid Arthritis J Rheumatol Suppl, June 1, 2009; 82(0): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Gayed, S Bernatsky, R Ramsey-Goldman, A. Clarke, and C Gordon Lupus and cancer Lupus, May 1, 2009; 18(6): 479 - 485. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Hemminki, X. Li, J. Sundquist, and K. Sundquist Cancer risks in Crohn disease patients Ann. Onc., March 1, 2009; 20(3): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, X. Li, K. Sundquist, and J. Sundquist Cancer risk in hospitalized rheumatoid arthritis patients Rheumatology, May 1, 2008; 47(5): 698 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kuriki, K. Wakai, K. Matsuo, A. Hiraki, T. Suzuki, Y. Yamamura, K. Yamao, T. Nakamura, M. Tatematsu, and K. Tajima Gastric Cancer Risk and Erythrocyte Composition of Docosahexaenoic Acid with Anti-inflammatory Effects Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2406 - 2415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Chai, Y.-C. Huang, W.-C. Hung, W.-Y. Kang, and W.-T. Chen Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells Mutagenesis, November 1, 2007; 22(6): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. M. Symmons Lymphoma and rheumatoid arthritis--again Rheumatology, January 1, 2007; 46(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Landgren, E. A. Engels, R. M. Pfeiffer, G. Gridley, L. Mellemkjaer, J. H. Olsen, K. F. Kerstann, W. Wheeler, K. Hemminki, M. S. Linet, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst, September 20, 2006; 98(18): 1321 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J H Mandel, M A Kelsh, P J Mink, D D Alexander, R M Kalmes, M Weingart, L Yost, and M Goodman Occupational trichloroethylene exposure and non-Hodgkin's lymphoma: a meta-analysis and review Occup. Environ. Med., September 1, 2006; 63(9): 597 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Onega, J. Baron, and T. MacKenzie Cancer after Total Joint Arthroplasty: A Meta-analysis. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1532 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R M Fleischmann, J Tesser, M H Schiff, J Schechtman, G-R Burmester, R Bennett, D Modafferi, L Zhou, D Bell, and B Appleton Safety of extended treatment with anakinra in patients with rheumatoid arthritis Ann Rheum Dis, August 1, 2006; 65(8): 1006 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M H Schiff, G R Burmester, J D Kent, A L Pangan, H Kupper, S B Fitzpatrick, and C Donovan Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis Ann Rheum Dis, July 1, 2006; 65(7): 889 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Franklin, M Lunt, D Bunn, D Symmons, and A Silman Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis Ann Rheum Dis, May 1, 2006; 65(5): 617 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Mikuls, J. O. Endo, S. E. Puumala, P. A. Aoun, N. A. Black, J. R. O'Dell, J. A. Stoner, E. C. Boilesen, M. A. Bast, D. A. Bergman, et al. Prospective Study of Survival Outcomes in Non-Hodgkin's Lymphoma Patients With Rheumatoid Arthritis J. Clin. Oncol., April 1, 2006; 24(10): 1597 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Fleischmann, S W Baumgartner, M H Weisman, T Liu, B White, and P Peloso Long term safety of etanercept in elderly subjects with rheumatic diseases Ann Rheum Dis, March 1, 2006; 65(3): 379 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Engels, J. R. Cerhan, M. S. Linet, W. Cozen, J. S. Colt, S. Davis, G. Gridley, R. K. Severson, and P. Hartge Immune-Related Conditions and Immune-Modulating Medications as Risk Factors for Non-Hodgkin's Lymphoma: A Case-Control Study Am. J. Epidemiol., December 15, 2005; 162(12): 1153 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zintzaras, M. Voulgarelis, and H. M. Moutsopoulos The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis Arch Intern Med, November 14, 2005; 165(20): 2337 - 2344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mazhar, R. Gillmore, and J. Waxman COX and cancer QJM, October 1, 2005; 98(10): 711 - 718. [Full Text] [PDF]
|
|
|
|
|
|
J Askling, C M Fored, L Brandt, E Baecklund, L Bertilsson, N Feltelius, L Coster, P Geborek, L T Jacobsson, S Lindblad, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists Ann Rheum Dis, October 1, 2005; 64(10): 1421 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Askling, C M Fored, E Baecklund, L Brandt, C Backlin, A Ekbom, C Sundstrom, L Bertilsson, L Coster, P Geborek, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists Ann Rheum Dis, October 1, 2005; 64(10): 1414 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Geborek, A Bladstrom, C Turesson, A Gulfe, I F Petersson, T Saxne, H Olsson, and L T H Jacobsson Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas Ann Rheum Dis, May 1, 2005; 64(5): 699 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Brown and R. N. DuBois COX-2: A Molecular Target for Colorectal Cancer Prevention J. Clin. Oncol., April 20, 2005; 23(12): 2840 - 2855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lindblad, J. Lagergren, and L. A. Garcia Rodriguez Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-h. Feng, J. I. Cohen, S. Fischer, L. Li, M. Sneller, R. Goldbach-Mansky, N. Raab-Traub, H.-J. Delecluse, and S. C. Kenney Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas J Natl Cancer Inst, November 17, 2004; 96(22): 1691 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Chang, T. Zheng, E. G. Weir, M. Borowitz, R. B. Mann, D. Spiegelman, and N. E. Mueller Aspirin and the Risk of Hodgkin's Lymphoma in a Population-Based Case-Control Study J Natl Cancer Inst, February 18, 2004; 96(4): 305 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Wang, J. Q. Huang, G. F. Zheng, S. K. Lam, J. Karlberg, and B. C.-Y. Wong Non-steroidal Anti-inflammatory Drug Use and the Risk of Gastric Cancer: A Systematic Review and Meta-analysis J Natl Cancer Inst, December 3, 2003; 95(23): 1784 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Feltelius, A Ekbom, and P Blomqvist Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study Ann Rheum Dis, December 1, 2003; 62(12): 1185 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Zhu and E. L. Schwartz Expression of the Angiogenic Factor Thymidine Phosphorylase in THP-1 Monocytes: Induction by Autocrine Tumor Necrosis Factor-{alpha} and Inhibition by Aspirin Mol. Pharmacol., November 1, 2003; 64(5): 1251 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Gelfand, J. Berlin, A. Van Voorhees, and D. J. Margolis Lymphoma Rates Are Low but Increased in Patients With Psoriasis: Results From a Population-Based Cohort Study in the United Kingdom Arch Dermatol, November 1, 2003; 139(11): 1425 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Herendeen and C. Lindley Use of NSAIDs for the Chemoprevention of Colorectal Cancer Ann. Pharmacother., November 1, 2003; 37(11): 1664 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Prindiville, T. Byers, F. R. Hirsch, W. A. Franklin, Y. E. Miller, K. O. Vu, H. J. Wolf, A. E. Baron, K. R. Shroyer, C. Zeng, et al. Sputum Cytological Atypia as a Predictor of Incident Lung Cancer in a Cohort of Heavy Smokers with Airflow Obstruction Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 987 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Harris, R. T. Chlebowski, R. D. Jackson, D. J. Frid, J. L. Ascenseo, G. Anderson, A. Loar, R. J. Rodabough, E. White, and A. McTiernan Breast Cancer and Nonsteroidal Anti-Inflammatory Drugs: Prospective Results from the Women's Health Initiative Cancer Res., September 15, 2003; 63(18): 6096 - 6101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Vuorela, T Sokka, E Pukkala, and P Hannonen Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis? Ann Rheum Dis, March 1, 2003; 62(3): 251 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Anderson, T. W. Johnson, D. Lazovich, and A. R. Folsom Association Between Nonsteroidal Anti-Inflammatory Drug Use and the Incidence of Pancreatic Cancer J Natl Cancer Inst, August 7, 2002; 94(15): 1168 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Thun, S. J. Henley, and C. Patrono Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues J Natl Cancer Inst, February 20, 2002; 94(4): 252 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Klimp, H. Hollema, C. Kempinga, A. G. J. van der Zee, E. G. E. de Vries, and T. Daemen Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Human Ovarian Tumors and Tumor-associated Macrophages Cancer Res., October 1, 2001; 61(19): 7305 - 7309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Signorello, W. Ye, J. P. Fryzek, L. Lipworth, J. F. Fraumeni Jr., W. J. Blot, J. K. McLaughlin, and O. Nyren Nationwide Study of Cancer Risk Among Hip Replacement Patients in Sweden J Natl Cancer Inst, September 19, 2001; 93(18): 1405 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. I. Kim, Y. C. Lee, K. H. Lee, J. H. Han, C. Y. Chon, Y. M. Moon, J. K. Kang, and I. S. Park Effects of Nonsteroidal Anti-Inflammatory Drugs on Helicobacter pylori-Infected Gastric Mucosae of Mice: Apoptosis, Cell Proliferation, and Inflammatory Activity Infect. Immun., August 1, 2001; 69(8): 5056 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Saukkonen, O. Nieminen, B. van Rees, S. Vilkki, M. Harkonen, M. Juhola, J.-P. Mecklin, P. Sipponen, and A. Ristimaki Expression of Cyclooxygenase-2 in Dysplasia of the Stomach and in Intestinal-type Gastric Adenocarcinoma Clin. Cancer Res., July 1, 2001; 7(7): 1923 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tharani, F. J. Dorey, and T. P. Schmalzried The Risk of Cancer Following Total Hip or Knee Arthroplasty J. Bone Joint Surg. Am., May 1, 2001; 83(5): 774 - 780. [Full Text] [PDF]
|
|
|
|
|
|
S. Srivastava, M. Verma, and D. E. Henson Biomarkers for Early Detection of Colon Cancer Clin. Cancer Res., May 1, 2001; 7(5): 1118 - 1126. [Abstract] [Full Text]
|
|
|
|
 |
|
 R J Farrell, Y Ang, P Kileen, D S O'Briain, D Kelleher, P W N Keeling, and D G Weir Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low Gut, October 1, 2000; 47(4): 514 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J S Langman, K K Cheng, E A Gilman, and R J Lancashire Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database BMJ, June 17, 2000; 320(7250): 1642 - 1646. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Vineis, P. Crosignani, C. Sacerdote, A. Fontana, G. Masala, L. Miligi, O. Nanni, V. Ramazzotti, S. Rodella, E. Stagnaro, et al. Haematopoietic cancer and medical history: a multicentre case control study J Epidemiol Community Health, June 1, 2000; 54(6): 431 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Coogan, L. Rosenberg, J. R. Palmer, B. L. Strom, A. G. Zauber, P. D. Stolley, and S. Shapiro Nonsteroidal Anti-Inflammatory Drugs and Risk of Digestive Cancers at Sites Other Than the Large Bowel Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 119 - 123. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Stevenson, M.-J. Zhao, A. Asea, C. N. Coleman, and S. K. Calderwood Salicylic Acid and Aspirin Inhibit the Activity of RSK2 Kinase and Repress RSK2-Dependent Transcription of Cyclic AMP Response Element Binding Protein- and NF-{kappa}B-Responsive Genes J. Immunol., November 15, 1999; 163(10): 5608 - 5616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. ASKLING, J. GRUNEWALD, A. EKLUND, G. HILLERDAL, and A. EKBOM Increased Risk for Cancer Following Sarcoidosis Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1668 - 1672. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Smith, B. Freidlin, L. A. G. Ries, and R. Simon RESPONSE: Re: Trends in Reported Incidence of Primary Malignant Brain Tumors in Children in the United States J Natl Cancer Inst, June 2, 1999; 91(11): 973b - 974b. [Full Text] [PDF]
|
|
|
|
|
|
E. Baecklund, A. Ekbom, P. Sparén, N. Feltelius, and L. Klareskog Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study BMJ, July 18, 1998; 317(7152): 180 - 181. [Full Text]
|
|
|
|
|
|
C. Paul, A. L. Tourneau, J. M. Cayuela, A. Devidas, C. Robert, V. Molinie, and L. Dubertret Epstein-Barr Virus-Associated Lymphoproliferative Disease During Methotrexate Therapy for Psoriasis Arch Dermatol, July 1, 1997; 133(7): 867 - 871. [Abstract] [PDF]
|
|
|
|
 |
|
 L.-E. Hansson, O. Nyren, A. W. Hsing, R. Bergstrom, S. Josefsson, W.-H. Chow, J. F. Fraumeni, and H.-O. Adami The Risk of Stomach Cancer in Patients with Gastric or Duodenal Ulcer Disease N. Engl. J. Med., July 25, 1996; 335(4): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Giovannucci, K. M. Egan, D. J. Hunter, M. J. Stampfer, G. A. Colditz, W. C. Willett, and F. E. Speizer Aspirin and the Risk of Colorectal Cancer in Women N. Engl. J. Med., September 7, 1995; 333(10): 609 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. I. Peleg and C. M. Wilcox Aspirin and the Risk of Digestive Cancers-Reply Arch Intern Med, January 23, 1995; 155(2): 214 - 217. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Waterhouse and D. Brenner Aspirin, NSAIDs, and Risk Reduction of Colorectal Cancer: The Problem Is Translation Arch Intern Med, February 28, 1994; 154(4): 366 - 368. [Abstract] [PDF]
|
|
|
|
|
|
I. I. Peleg, H. T. Maibach, S. H. Brown, and C. M. Wilcox Aspirin and Nonsteroidal Anti-inflammatory Drug Use and the Risk of Subsequent Colorectal Cancer Arch Intern Med, February 28, 1994; 154(4): 394 - 400. [Abstract] [PDF]
|
|